A preclinical study to investigate the development of nephrogenic systemic fibrosis: a possible role for gadolinium-based contrast media.
about
Gadolinium-based contrast agent toxicity: a review of known and proposed mechanisms25 Years of Contrast-Enhanced MRI: Developments, Current Challenges and Future PerspectivesNanoparticle contrast agents for computed tomography: a focus on micellesZero echo time magnetic resonance imaging of contrast-agent-enhanced calcium phosphate bone defect fillers.MRI contrast agents: basic chemistry and safety.Practical dynamic contrast enhanced MRI in small animal models of cancer: data acquisition, data analysis, and interpretationGadolinium-containing magnetic resonance contrast media: investigation on the possible transchelation of Gd³⁺ to the glycosaminoglycan heparin.Inorganic nanocrystals as contrast agents in MRI: synthesis, coating and introduction of multifunctionality.Is macrocycle a synonym for kinetic inertness in Gd(III) Complexes? Effect of coordinating and noncoordinating substituents on inertness and relaxivity of Gd(III) chelates with DO3A-like ligands.A simple approach to a new T8-POSS based MRI contrast agent.High-relaxivity gadolinium-modified high-density lipoproteins as magnetic resonance imaging contrast agentsPrimer on gadolinium chemistry.High relaxivity trimetallic nitride (Gd3N) metallofullerene MRI contrast agents with optimized functionality.Collagenolytic activity is suppressed in organ-cultured human skin exposed to a gadolinium-based MRI contrast agentPathophysiology of nephrogenic systemic fibrosis: A review of experimental data.Quantification and Assessment of the Chemical Form of Residual Gadolinium in the Brain After Repeated Administration of Gadolinium-Based Contrast Agents: Comparative Study in Rats.Regulation of collagen turnover in human skin fibroblasts exposed to a gadolinium-based contrast agent.Gain of a 500-fold sensitivity on an intravital MR contrast agent based on an endohedral gadolinium-cluster-fullerene-conjugate: a new chance in cancer diagnosticsThe fate of Gd and chelate following intravenous injection of gadodiamide in rats.Nephrogenic systemic fibrosis is associated with hypophosphataemia: a case-control study.Type of MRI contrast, tissue gadolinium, and fibrosis.Substitution of gadolinium ethylenediaminetetraacetate with phosphites: towards gadolinium deposit in nephrogenic systemic fibrosis.Fibroblast response to gadolinium: role for platelet-derived growth factor receptorResponses of human skin in organ culture and human skin fibroblasts to a gadolinium-based MRI contrast agent: comparison of skin from patients with end-stage renal disease and skin from healthy subjects.Total gadolinium tissue deposition and skin structural findings following the administration of structurally different gadolinium chelates in healthy and ovariectomized female rats.In vivo differentiation of complementary contrast media at dual-energy CT.Functional immunoassay technology (FIT), a new approach for measuring physiological functions: application of FIT to measure glomerular filtration rate (GFR).A peptide targeted contrast agent specific to fibrin-fibronectin complexes for cancer molecular imaging with MRI.Gadolinium - is it to blame?Gadolinium-containing magnetic resonance image contrast agent promotes fibrocyte differentiation.Evaluation of CLT1-(Gd-DTPA) for Cancer MR Molecular Imaging in a Mouse Breast Cancer Model.Nanoparticles: small and mighty.Update on nephrogenic systemic fibrosis: are we making progress?Comparison of contrast-enhanced multi-station MR angiography and digital subtraction angiography of the lower extremity arterial disease.Gadobutrol: a review of its use for contrast-enhanced magnetic resonance imaging in adults and children.Engineering Gd-loaded nanoparticles to enhance MRI sensitivity via T(1) shortening.The role of gadolinium chelates in the mechanism of nephrogenic systemic fibrosis: A critical update.The biodistribution of [153Gd]Gd-labeled magnetic resonance contrast agents in a transgenic mouse model of renal failure differs greatly from control mice.The Impact of Excess Ligand on the Retention of Nonionic, Linear Gadolinium-Based Contrast Agents in Patients With Various Levels of Renal Dysfunction: A Review and Simulation Analysis.Lipoproteins and lipoprotein mimetics for imaging and drug delivery.
P2860
Q26751073-75A8EC66-B86F-4C90-B4CF-2EED77E9E013Q26774810-BBFA13EB-21BF-4CBB-9784-A0B4977F4AA8Q26863316-258DA5EA-C2F3-4FE7-B844-60A0442578F1Q30559902-5E930B3D-ABBF-4C49-A226-761AAC94BC2DQ30574482-1EFCD6F9-EFDC-4173-A394-F5A41B085F85Q30575110-A1C30C85-C8DD-413B-A033-31C7AB72AD8BQ30583956-30D4C93A-D41E-4D9E-BA08-5EFBA0161393Q30585395-0DAC491E-7C42-4274-B123-2065D839417CQ30604750-C243EE58-3E4F-4F8D-BADC-C9F219F54E92Q31135238-8A1FBD6B-47D4-4233-BCE3-D0345767C264Q33429230-B1A72FA2-A776-48F5-80F6-E9B85FF8E950Q33516622-EF2D531B-75ED-42A5-806B-E5FAFBE07969Q33539375-229AAE5E-C05C-4168-90EA-2D6517A35CD9Q33641250-E34609DD-C2FF-4BD4-B599-5C29ED75C10FQ33778292-F26F1349-EC56-42CA-99D9-8C8897142F48Q33778968-1708FE1C-74E8-4D19-96BB-98D87874CCEFQ33809662-3A06F64F-254D-450E-8861-4436C12C0E78Q33894429-2729B74C-67A3-4B34-96D1-9FEBCA1611B7Q33899096-2BB91255-4599-4F4C-8E95-3B633B96BEF3Q34056490-F0E2079F-9524-40CD-A0E4-AF8188333CDCQ34602036-D2E015AC-7B77-4F33-8E3E-C24150A762E4Q35019353-3D4CA234-203D-4D8A-9263-DECEA988A65CQ35187914-66D190F7-8981-4A83-9A02-61201B7BC44FQ35187986-AC2D4356-CEB3-4ADD-85AE-9C4F560FEA48Q36027601-852BB025-1D07-4BE3-A366-6A2511916587Q36247842-430F485B-977E-448D-9DB7-61E5C7F75131Q36977447-3A6E42E5-9DE3-400D-B949-9B5BD52F6FFEQ37118318-2CE6F830-E4CD-4BDE-AE71-48414E5094D8Q37133328-31C7CEC3-944A-414E-B9D9-99EBF4A4A020Q37456116-3FD9E2F5-03C7-4343-87E1-5B13577C4D5CQ37490152-EC8097EB-4B4E-4FE6-B19C-038F97E21121Q37845900-AC7654BD-28F9-4E50-9E78-6AF63BDB1C84Q37877286-D453CCB4-5B0C-40DF-B9E0-B963F89CA020Q38063187-672D5C0A-E05C-48D0-9258-9387BB55F41EQ38084164-4899F74D-485E-42B2-8736-AF5FB22F83A3Q38155457-2098EEDD-B8D3-482D-A81D-CAAE53AD4264Q38254508-7743F047-6567-4F00-8CB1-0F4F3A809F1FQ38570145-CCBF8865-94B8-4178-941A-94FD7D50530EQ38788045-0FF97C85-F6FF-4196-86B3-FD652CF251ABQ38822339-71762F0D-CCA1-42B5-979F-870403362F9B
P2860
A preclinical study to investigate the development of nephrogenic systemic fibrosis: a possible role for gadolinium-based contrast media.
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年学术文章
@wuu
2008年学术文章
@zh-cn
2008年学术文章
@zh-hans
2008年学术文章
@zh-my
2008年学术文章
@zh-sg
2008年學術文章
@yue
2008年學術文章
@zh
2008年學術文章
@zh-hant
name
A preclinical study to investi ...... dolinium-based contrast media.
@en
A preclinical study to investi ...... dolinium-based contrast media.
@nl
type
label
A preclinical study to investi ...... dolinium-based contrast media.
@en
A preclinical study to investi ...... dolinium-based contrast media.
@nl
prefLabel
A preclinical study to investi ...... dolinium-based contrast media.
@en
A preclinical study to investi ...... dolinium-based contrast media.
@nl
P2093
P1476
A preclinical study to investi ...... dolinium-based contrast media.
@en
P2093
Hanns-Joachim Weinmann
Hubertus Pietsch
Jakob Walter
Martin A Sieber
Thomas Frenzel
Wolfram Haider
P356
10.1097/RLI.0B013E31815E6277
P577
2008-01-01T00:00:00Z